ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,234Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 298

$676K Total Retail Price of All Prescriptions

Rank: 9 out of 298

498 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,648 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
FUROSEMIDE 395 343 1 5
SIMVASTATIN 393 356 2 2
AMLODIPINE BESYLATE 388 341 3 6
WARFARIN SODIUM 364 354 4 7
HYDROCODONE-ACETAMINOPHEN 312 234 S3 5 8
LEVOTHYROXINE SODIUM 283 234 6 1
METFORMIN HCL 260 209 7 10
LISINOPRIL 252 202 8 4
TRAMADOL HCL 251 157 9 15
POTASSIUM CHLORIDE 250 221 10 11
OMEPRAZOLE 239 187 11 3
FENTANYL 226 163 S2 12 32
LOSARTAN POTASSIUM 224 199 13 18
METOPROLOL SUCCINATE 182 157 14 12
TRAZODONE HCL 177 154 15 39
SERTRALINE HCL 174 156 16 19
TAMSULOSIN HCL 160 157 17 24
RAMIPRIL 155 155 18 84
ATORVASTATIN CALCIUM 142 91 19 14
CARBIDOPA-LEVODOPA 134 123 20 49
CITALOPRAM HBR 123 108 21 17
GLIMEPIRIDE 111 111 22 60
SYNTHROID 110 91 23 42
METOPROLOL TARTRATE 104 91 24 9
CHLORTHALIDONE 100 92 25 158
PRAVASTATIN SODIUM 98 76 26 31
DONEPEZIL HCL 96 72 27 22
JANUVIA 94 79 28 73
KLOR-CON 10 93 85 29 61
FINASTERIDE 91 91 30 66
CYMBALTA 83 48 31 67
AZITHROMYCIN 81 60 32 63
ZOLPIDEM TARTRATE 80 12 33 25
GABAPENTIN 77 48 34 20
PREDNISONE 76 63 35 33
MELOXICAM 73 41 36 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 53 36 30
ALENDRONATE SODIUM 72 71 38 21
FENOFIBRATE 70 48 39 62
CIPROFLOXACIN HCL 69 57 40 56
CLOPIDOGREL 68 65 41 36
HYDROCHLOROTHIAZIDE 67 46 42 13
BENAZEPRIL HCL 64 57 43 52
OXYCODONE HCL 64 19 S2 43 79
ESCITALOPRAM OXALATE 64 39 43 89
RANITIDINE HCL 64 52 43 59
CARVEDILOL 63 57 47 23
SPIRIVA 62 62 48 55
CRESTOR 61 28 49 26
POLYETHYLENE GLYCOL 3350 59 52 50 29
PROPRANOLOL HCL 59 56 50 85
FLUTICASONE PROPIONATE 58 38 52 38
EVISTA 58 46 52 134
FAMOTIDINE 58 58 52 80
DIGOXIN 58 48 52 27
ATENOLOL 57 50 56 16
ROPINIROLE HCL 57 57 56 117
PRAMIPEXOLE DIHYDROCHLORIDE 57 46 56 114
PROAIR HFA 56 38 59 96
SYMBICORT 53 45 60 231
AMITRIPTYLINE HCL 53 18 R 60 51
OXYCONTIN 52 0 S2 62 162
NOVOLOG 52 51 62 102
NAMENDA 52 40 62 35
LANTUS 52 52 62 53
ALLOPURINOL 50 49 66 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.